TFREsCHO

Hui-Ning Liu1,2, Xiao-Yin Wang1,3, Ying Zou1,3

  • 1International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang 453003, China.

Heliyon
|March 12, 2024
PubMed
概括

合成增强剂通过优化细胞巨乳病毒 (CMV) 促进体,显著提高了中国仓鼠卵巢 (CHO) 细胞的重组蛋白质生产. 这一进展对于开发治疗性蛋白质的高产量CHO细胞表达系统至关重要.